Stoke Therapeutics
STOK
#5004
Rank
NZ$3.20 B
Marketcap
NZ$49.01
Share price
-0.45%
Change (1 day)
-6.21%
Change (1 year)

EPS for Stoke Therapeutics (STOK)

EPS in 2026 (TTM): NZ-$6.05

According to Stoke Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$6.31. In 2024 the company made an earnings per share (EPS) of NZ-$3.07.

EPS history for Stoke Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.05
2024NZ-$3.07
2022NZ-$4.7511.59%
2021NZ-$4.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47-60.87%๐Ÿ‡บ๐Ÿ‡ธ USA